Perspective Therapeutics, Inc. — Director's Dealing 2020

Oct 28, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Isoray, Inc. (ISR)
CIK: 0000728387
Period of Report: 2020-10-22

Reporting Person: Vitale Philip J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-22	Common Stock	P	20000	$0.52	Acquired	130000	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-22	Warrant (right to buy)	$0.57	P	10000	Acquired	2025-10-22	Common Stock (10000)	Indirect

Footnotes

F1: Purchased pursuant to public offering that closed on October 22, 2020.

F2: Purchased pursuant to public offering that closed on October 22, 2020. Each share of common stock purchased included one-half of a warrant. Each whole warrant is exercisable to purchase one share of common stock at an exercise price of $0.57 per share. Each warrant is immediately exercisable, and will expire October 22, 2025.